*ZOETIS RECEIVES EUROPEAN COMMISSION MARKETING AUTHORIZATION FOR PORTELA® (RELFOVETMAB) TO ALLEVIATE PAIN ASSOCIATED WITH OSTEOARTHRITIS IN CATS
*ZOETIS INC - ANTICIPATES PORTELA AVAILABILITY IN EU IN 2026
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 29-OCT-202512:30:00.16 GMT